Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is well positioned to continue to gain share in the pet food category, and the company's focus on premiumization and vet-based/scientific-focused nutrition aligns with the current market trends. Despite softer US category momentum, Colgate-Palmolive has maintained its top- and bottom-line guidance and has multiple levers to mitigate cost pressures in a volatile environment. With a solid execution track record, Colgate-Palmolive is expected to achieve its sustainability targets and integrate sustainability considerations into its strategy. However, the company may face potential risks from spiking resin costs, which could potentially impact its earnings in the future.

Bears say

Colgate-Palmolive is a leading player in the household and personal care industry with strong international presence and diversified product portfolio. However, negative factors such as volatility in emerging market currencies, fluctuation in input costs and increased competitive activity in core markets may hinder its organic sales growth and profitability in the future. In addition, the company's exposure to higher resin and oil derivative costs, along with macroeconomic uncertainty and potential recessionary pressures, pose further risks to its financial performance and could impact its share price in the short to medium term.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Aug 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.